Cefiderocol Sulfate Tosylate/Xeruborbactam

N/A

Report date: 2026/02/11 20:01:36

Base Information

Drug NameCefiderocol Sulfate Tosylate/Xeruborbactam
Drug Alias NameXeruborbactam/CefiderocolCefiderocol/QPX7728S-649228
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Cefiderocol Sulfate TosylateXeruborbactam
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesQpex Biopharma IncShionogi Inc
China Registration ClassN/A

Develop Information

Active CompaniesShionogi IncQpex Biopharma Inc
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A